Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antithrombin: structure, genomic organization, function and inherited deficiency.

D A Lane, R Caso

    Bailliere'S Clinical Haematology
    |October 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Stop and Go: Barriers and Facilitators to Care Home Research.

    The Journal of frailty & aging·2023
    Same author

    Enhanced activity of an ADAMTS-13 variant (R568K/F592Y/R660K/Y661F/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic stroke.

    Journal of thrombosis and haemostasis : JTH·2018
    Same author

    ADAMTS-13 and von Willebrand factor: a dynamic duo.

    Journal of thrombosis and haemostasis : JTH·2017
    Same author

    Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial.

    Journal of internal medicine·2017
    Same author

    Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity: reply.

    Journal of thrombosis and haemostasis : JTH·2017
    Same author

    Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity.

    Journal of thrombosis and haemostasis : JTH·2016

    Antithrombin is a key regulator of blood coagulation. Its gene structure and polymorphisms are analyzed, revealing insights into inherited deficiencies and familial thromboembolism.

    Area of Science:

    • Biochemistry
    • Genetics
    • Molecular Biology

    Background:

    • Antithrombin is a crucial plasma protein inhibitor regulating blood coagulation, particularly thrombin activity.
    • Heparin significantly accelerates antithrombin's anticoagulant function through specific binding interactions.
    • Endothelial cell-bound heparan sulfate proteoglycans also mediate antithrombin's acceleratory mechanism in vivo.

    Purpose of the Study:

    • To characterize the gene structure of antithrombin, including regulatory regions and polymorphisms.
    • To investigate the evolutionary relationships of antithrombin within the serine proteinase inhibitor superfamily.
    • To explore the genetic basis of inherited antithrombin deficiency and its association with thromboembolism.

    Main Methods:

    • Gene mapping and sequencing to determine antithrombin gene organization.

    Related Experiment Videos

  • Identification and characterization of promoter and enhancer elements.
  • Analysis of intragenic and upstream polymorphisms.
  • Investigation of mutation sites in CpG dinucleotides.

    • Main Results:

    • The antithrombin gene organization and protein structure are related to the serine proteinase inhibitor superfamily.
    • Absence of a TATA-like promoter sequence, but presence of two homologous enhancer sequences.
    • Two polymorphisms identified: a silent codon 305 transition and a length polymorphism upstream of the translation start site.
    • Mutations in CpG dinucleotides suggest they are potential mutation hotspots.

    Conclusions:

    • Understanding antithrombin gene structure and polymorphisms is vital for studying inherited deficiencies.
    • Familial thromboembolism is linked to inherited antithrombin deficiency, with ongoing investigation into molecular genetic causes.
    • CpG dinucleotides may represent mutation hotspots in the human genome, relevant to antithrombin deficiency.